The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Adriamycin-induced heart failure: mechanisms and modulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
Self-citationCarnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430
Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor Response
Myers, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., & Young, R. C. (1977) · Science · doi:10.1126/science.877547 · Cited by 1,111
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Steinherz, L. J. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470120074036 · Cited by 989
Apoptosis in human acute myocardial infarction.
Saraste, A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M., & Voipio-Pulkki, L.-M. (1997) · Circulation · doi:10.1161/01.cir.95.2.320 · Cited by 825
The Anthracycline Antineoplastic Drugs
Young, R. C., Ozols, R. F., & Myers, C. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198107163050305 · Cited by 793
Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous Infusion
LEGHA, S. S., BENJAMIN, R. S., MACKAY, B., EWER, M., WALLACE, S., VALDIVIESO, M., RASMUSSEN, S. L., BLUMENSCHEIN, G. R., & FREIREICH, E. J. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-133 · Cited by 763
Enzymatic Defenses of the Mouse Heart Against Reactive Oxygen Metabolites
Doroshow, J. H., Locker, G. Y., & Myers, C. E. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109642 · Cited by 702
Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
Doroshow, J. H. (1983) · PubMed · Cited by 629
Adriamycin, 14‐hydroxydaimomycin, a new antitumor antibiotic from S. Peucetius var. caesius
Arcamone, F., Cassinelli, G., Fantini, G., Grein, A., Orezzi, P., Pol, C., & Spalla, C. (1969) · Biotechnology and Bioengineering · doi:10.1002/bit.260110607 · Cited by 622
Probucol inhibits oxidative modification of low density lipoprotein.
Parthasarathy, S., Young, S. G., Witztum, J. L., Pittman, R. C., & Steinberg, D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112349 · Cited by 618
Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty
Tardif, J.-C., Côté, G., Lespérance, J., Bourassa, M., Lambert, J., Doucet, S., Bilodeau, L., Nattel, S., & de Guise, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370601 · Cited by 565
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
RELATION BETWEEN SERUM-FREE-FATTY-ACIDS AND ARRHYTHMIAS AND DEATH AFTER ACUTE MYOCARDIAL INFARCTION
OLIVER, M. (1968) · The Lancet · doi:10.1016/s0140-6736(68)92163-6 · Cited by 515
Subcellular effects of adriamycin in the heart: A concise review
SINGAL, P., DEALLY, C., & WEINBERG, L. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80392-9 · Cited by 465
Self-citationEarly anthracycline cardiotoxicity
Bristow, M. R., Thompson, P. D., Martin, R. P., Mason, J. W., Billingham, M. E., & Harrison, D. C. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90802-1 · Cited by 334
Doroshow, J. H. (1983) · PubMed · Cited by 329
Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure.
Sharov, V. G., Sabbah, H. N., Shimoyama, H., Goussev, A., Lesch, M., & Goldstein, S. (1996) · Europe PMC (PubMed Central) · Cited by 324
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
Speyer, J. L., Green, M. D., Zeleniuch-Jacquotte, A., Wernz, J. C., Rey, M., Sanger, J., Kramer, E., Ferrans, V, Hochster, H., & Meyers, M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.117 · Cited by 322
Kalyanaraman, B., Perez-Reyes, E., & Mason, R. P. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90142-7 · Cited by 317
Adriamycin cardiomyopathy: pathophysiology and prevention
Singal, P. K., Iliskovic, N., Li, T., & Kumar, D. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337145 · Cited by 310
Self-citationProbucol Protects Against Adriamycin Cardiomyopathy Without Interfering With Its Antitumor Effect
Siveski-Iliskovic, N., Hill, M., Chow, D. A., & Singal, P. K. (1995) · Circulation · doi:10.1161/01.cir.91.1.10 · Cited by 285
Self-citationPhase I and preliminary phase II evaluation of adriamycin (NSC 123127).
Bonadonna, G., Monfardini, S., Lena, M. D., Fossati‐Bellani, F., & Beretta, G. (1970) · PubMed · Cited by 278
Siveski-Iliskovic, N., Kaul, N., & Singal, P. K. (1994) · Circulation · doi:10.1161/01.cir.89.6.2829 · Cited by 265
Self-citationPrevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine.
Doroshow, J. H., Locker, G. Y., Ifrim, I., & Myers, C. E. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110328 · Cited by 245
Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.
Marco, A. D., Gaetani, M., & Scarpinato, B. (1969) · PubMed · Cited by 243
Pryor, W. A., Strickland, T., & Church, D. F. (1988) · Journal of the American Chemical Society · doi:10.1021/ja00215a036 · Cited by 239
Electrolyte and morphologic alterations of myocardium in adriamycin-treated rabbits.
Olson, H. M., Young, D. M., Prieur, D. J., LeRoy, A. F., & Reagan, R. L. (1974) · PubMed Central · Cited by 237
Effects of probucol on xanthomata regression in familial hypercholesterolemia
Yamamoto, A., Matsuzawa, Y., Yokoyama, S., Funahashi, T., Yamamura, T., & Kishino, B.-I. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90434-0 · Cited by 230
Anthracycline Antibiotics in Cancer Therapy: Focus on Drug Resistance
Booser, D. J., & Hortobagyi, G. N. (1994) · Drugs · doi:10.2165/00003495-199447020-00002 · Cited by 214
Kaul, N., Siveski-Iliskovic, N., Hill, M., Slezak, J., & Singal, P. K. (1993) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/1056-8719(93)90008-3 · Cited by 199
Self-citationHearse, D. J. (1991) · PubMed · Cited by 185
Yokoi, H., Daida, H., Kuwabara, Y., Nishikawa, H., Takatsu, F., Tomihara, H., Nakata, Y., Kutsumi, Y., Ohshima, S., Nishiyama, S., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00270-2 · Cited by 184
Bristow, M. R., Sageman, W. S., Scott, R. H., Billingham, M. E., Bowden, R. E., Kernoff, R. S., Snidow, G. H., & Daniels, J. R. (1980) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198009000-00002 · Cited by 171
Vleet, J. F. V., Ferrans, V. J., & Weirich, W. E. (1980) · PubMed · Cited by 169
Gianni, L., Zweier, J. L., Levy, A., & Myers, C. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88854-8 · Cited by 154
Hydroxyl radical production and DNA damage induced by anthracycline‐iron complex
Muindi, J. R., Sinha, B. K., Gianni, L., & Myers, C. E. (1984) · FEBS Letters · doi:10.1016/0014-5793(84)81130-8 · Cited by 150
Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
Olson, R. D., MacDonald, J. S., VanBoxtel, C. J., Boerth, R. C., Harbison, R. D., Slonim, A. E., Freeman, R. W., & Oates, J. A. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32319-0 · Cited by 147
Dexrazoxane in the Prevention of Doxorubicin-Induced Cardiotoxicity
Seifert, C. F., Nesser, M. E., & Thompson, D. F. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800912 · Cited by 139
Zhang, J. H., Clark, J. R., Herman, E. H., & Ferrans, V. J. (1996) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0186 · Cited by 132
Combination therapy with probucol prevents adriamycin-induced cardiomyopathy
Singal, P. K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90074-8 · Cited by 131
Self-citationMyocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats
Tong, J., Ganguly, P. K., & Singal, P. K. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.3.h909 · Cited by 129
Self-citationSvingen, B. A., & Powis, G. (1981) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(81)90263-0 · Cited by 122
A relative deficit in antioxidant reserve may contribute in cardiac failure.
Singal, P. K., & Kirshenbaum, L. A. (1990) · PubMed · Cited by 121
Self-citationAscorbic acid and adriamycin toxicity
Shimpo, K., Nagatsu, T., Yamada, K., Sato, T., Niimi, H., Shamoto, M., Takeuchi, T., Umezawa, H., & Fujita, K. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.6.1298s · Cited by 119
Antioxidant activity of probucol and its analogs in hypercholesterolemic Watanabe rabbits
Mao, S. J. T., Yates, M. T., Rechtin, A., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00105a046 · Cited by 116
Lipid lowering: an important factor in preventing adriamycin-induced heart failure.
Iliskovic, N., & Singal, P. K. (1997) · Europe PMC (PubMed Central) · Cited by 114
Self-citationHerman, E. H., & Ferrans, V. J. (1981) · PubMed · Cited by 108
Singal, P. K., & Pierce, G. N. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.3.h419 · Cited by 105
Self-citationHypocholesterolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)
Barnhart, J. W., Sefranka, J. A., & MCINTOSH, D. D. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.9.1229 · Cited by 102
Apoptosis in Isolated Adult Cardiomyocytes Exposed to Adriamycina
Kumar, D., Kirshenbaum, L. A., Li, T., Danelisen, I., & Singal, P. K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09233.x · Cited by 99
Self-citationBreed, J. G. S., Zimmerman, A. N. E., Dormans, J. A. M. A., & Pinedo, H. M. (1980) · PubMed · Cited by 94
Averill‐Bates, D. A., & Winterbourn, C. C. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81222-2 · Cited by 91
Sehested, M., Jensen, P. B., Sørensen, B. S., Holm, B., Friche, E., & Demant, E. J. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90514-w · Cited by 91
Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy.
Kaul, N., Siveski-Iliskovic, N., Thomas, T. P., et al. (1996) · PubMed · Cited by 80
Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestine
Odom, A., Hatwig, C. A., Stanley, J. S., & Benson, A. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90250-m · Cited by 76
Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity.
Jackson, J. A., Reeves, J., Muntz, K. H., Kruk, D., Prough, R. A., Willerson, J. T., & Buja, L. M. (1984) · PubMed · Cited by 75
Effects of adriamycin on heart mitochondrial function in rested and exercised rats
Ji, L. L., & Mitchell, E. W. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90488-x · Cited by 70
Model Systems for Cardiotoxic Effects of Anthracyclines
Zbinden, G., Bachmann, E., & Holderegger, C. (2015) · Antibiotics and chemotherapy/Antibiotica et chemotherapia · doi:10.1159/000401489 · Cited by 65
Free radical production from normal and adriamycin-treated rat cardiac sarcosomes
Thornalley, P. J., & Dodd, N. J. F. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90262-x · Cited by 61
Adriamycin-induced lipid peroxidation in mitochondria and microsomes
Griffin-Green, E. A., Zaleska, M. M., & Erecińska, M. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90303-6 · Cited by 60
Gutteridge, J. M. C., & Toeg, D. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81106-x · Cited by 52
Speyer, J. L., Green, M. D., Dubin, N., Blum, R. H., Wernz, J., Roses, D. F., Sanger, J. J., & Muggia, F. M. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90395-x · Cited by 52
Phase I study of ICRF-187 using a daily for 3 days schedule.
Hoff, V., Howser, D. M., Bj, L., Holcenberg, J. S., Weiss, R. B., & Rc, Y. (1981) · PubMed · Cited by 45
Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: a spin-trapping study
Alegría, A. E., Samuni, A. M., Mitchell, J. B., Riesz, P., & Russo, A. (1989) · Biochemistry · doi:10.1021/bi00447a056 · Cited by 40
Vile, G. F., & Winterbourn, C. C. (1990) · PubMed · Cited by 30
Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes
Singal, P. K., & Tong, J. (1988) · Molecular and Cellular Biochemistry · doi:10.1007/bf00421051 · Cited by 29
Self-citationIliskovic, N., Li, T., Khaper, N., Palace, V. P., & Singal, P. K. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5763-0_17 · Cited by 27
Self-citationIliskovic, N., Li, T., Khaper, N., Palace, V. P., & Singal, P. K. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006845120287 · Cited by 24
Self-citationPlasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis
Joles, J. A., van Tol, A., Jansen, E., Koomans, H. A., Rabelink, T. J., Grond, J., & van Goor, H. (1993) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/8.9.831 · Cited by 12
Direct detection of paramagnetic species in adriamycin perfused rat hearts
Costa, L. E., Malatesta, V., Morazzoni, F., Scotti, R., Monti, E., & Paracchini, L. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81218-x · Cited by 11
Cited by
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
McCubrey, J. A., Steelman, L. S., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Chang, F., Lehmann, B., Terrian, D. M., Milella, M., Tafuri, A., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.10.001 · Cited by 2,284
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Metadata
- Authors
- Singal, P., Li, T., Kumar, D., Danelisen, I., & Iliskovic, N.
- Venue
- Molecular and Cellular Biochemistry
- Published
- 2000-04
- Volume
- 207
- Issue
- 1-2
- Pages
- 77-86
- ISSN
- 0300-8177 (ISSN-L)
- 1573-4919
- OpenAlex
- W1596495551
- Cited by
- 428
- References
- 74
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.